Galderma to hold launch event for Alluzience
Pharmaceutical company Galderma is hosting a launch event for its new liquid neuromodulator Alluzience.
Pharmaceutical company Galderma is hosting a launch event for its new liquid neuromodulator Alluzience.
The Joint Council for Cosmetic Practitioners (JCCP) has announced a national survey looking into patients’ experiences of botulinum toxin complications in the UK.
Skin rejuvenation company Skinade has expanded its portfolio with a range of products to help medical practitioners care for patients following injectable treatments.
Dr Martyn King provides an introduction into complications caused by botulinum toxin injections and outlines the methods of prevention
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
Aesthetics training provider Cosmetic Courses has launched a new botulinum toxin training course.
The Advertising Standards Authority (ASA) has upheld two complaints issued by the Joint Council of Cosmetic Practitioners (JCCP) against Secret Surgery Ltd.
Pharmaceutical company Galderma has released the results of its two phase III studies for its liquid formulation of botulinumtoxinA (relabotulinumtoxinA).
Canadian aesthetic practitioner and pioneer of the use of botulinum toxin for wrinkles, Dr Jean Carruthers will present at the British College of Aesthetic Medicine (BCAM) Conference in September.
Aesthetic manufacturer Croma-Pharma has announced the national approval of its new botulinum toxin in the UK.
Aesthetic practitioner Dr Patrick Treacy will be hosting a complications conference in July.